LPL Financial’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$745K Sell
267,200
-58,056
-18% -$177K ﹤0.01% 4418
2025
Q4
$1.35M Sell
325,256
-35,012
-10% -$184K ﹤0.01% 3763
2025
Q3
$1.53M Sell
360,268
-6,710
-2% -$25.2K ﹤0.01% 3579
2025
Q2
$774K Buy
366,978
+173,500
+90% +$260K ﹤0.01% 3986
2025
Q1
$236K Buy
193,478
+54,550
+39% +$76.5K ﹤0.01% 4742
2024
Q4
$179K Buy
138,928
+57,020
+70% +$137K ﹤0.01% 4848
2024
Q3
$225K Sell
81,908
-5,350
-6% -$13.1K ﹤0.01% 4644
2024
Q2
$197K Buy
87,258
+32,196
+58% +$97.8K ﹤0.01% 4575
2024
Q1
$132K Buy
55,062
+3,250
+6% +$6.15K ﹤0.01% 4619
2023
Q4
$86K Hold
51,812
﹤0.01% 4578
2023
Q3
$99.5K Hold
51,812
﹤0.01% 4417
2023
Q2
$74.6K Sell
51,812
-500
-1% -$848 ﹤0.01% 4378
2023
Q1
$110K Sell
52,312
-10,261
-16% -$16.6K ﹤0.01% 4191
2022
Q4
$70.7K Buy
62,573
+500
+0.8% +$666 ﹤0.01% 4225
2022
Q3
$101K Buy
62,073
+3,539
+6% +$6.61K ﹤0.01% 4107
2022
Q2
$77K Hold
58,534
﹤0.01% 4176
2022
Q1
$94K Buy
58,534
+10,900
+23% +$21.1K ﹤0.01% 3987
2021
Q4
$99K Sell
47,634
-1,900
-4% -$5.42K ﹤0.01% 4139
2021
Q3
$192K Sell
49,534
-2,500
-5% -$8.47K ﹤0.01% 4000
2021
Q2
$167K Buy
52,034
+35,750
+220% +$127K ﹤0.01% 3957
2021
Q1
$35K Sell
16,284
-1,300
-7% -$2.91K ﹤0.01% 4021
2020
Q4
$39K Sell
17,584
-1,000
-5% -$2.62K ﹤0.01% 3745
2020
Q3
$50K Sell
18,584
-9,649
-34% -$27K ﹤0.01% 3436
2020
Q2
$86K Buy
28,233
+1,722
+6% +$4.33K ﹤0.01% 3310
2020
Q1
$52K Hold
26,511
﹤0.01% 3084
2019
Q4
$76K Hold
26,511
﹤0.01% 3250
2019
Q3
$97K Sell
26,511
-3,200
-11% -$11.6K ﹤0.01% 3147
2019
Q2
$123K Sell
29,711
-2,166
-7% -$9.38K ﹤0.01% 3134
2019
Q1
$163K Buy
31,877
+3,000
+10% +$14.4K ﹤0.01% 2999
2018
Q4
$99K Sell
28,877
-916
-3% -$4.38K ﹤0.01% 2957
2018
Q3
$179K Sell
29,793
-1,000
-3% -$5.5K ﹤0.01% 3025
2018
Q2
$196K Buy
30,793
+7,200
+31% +$35.1K ﹤0.01% 2985
2018
Q1
$112K Buy
+23,593
New +$110K ﹤0.01% 3061

Other funds holding GALT